Analyst Expectations for Pharvaris’s Future

Analysts have provided the following ratings for Pharvaris (NASDAQ:PHVS) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

Analysts have provided the following ratings for Pharvaris (NASDAQ:PHVS) within the last quarter:

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 0 1 4 0 0
Last 30D 0 0 1 0 0
1M Ago 0 0 2 0 0
2M Ago 0 0 1 0 0
3M Ago 0 1 0 0 0

In the last 3 months, 5 analysts have offered 12-month price targets for Pharvaris. The company has an average price target of $12.0 with a high of $20.00 and a low of $10.00.

Below is a summary of how these 5 analysts rated Pharvaris over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and the greater the number of bearish ratings, the more negative analysts are on the stock

price target chart

This current average has increased by 20.0% from the previous average price target of $10.00.

Stay up to date on Pharvaris analyst ratings.

If you are interested in following small-cap stock news and performance you can start by tracking it here.

What Are Analyst Ratings?

Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.

Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Alibaba Ramps Up Investment in Growth, Analysts Adjust Forecast Amid Strategic Pivot

Fawne Jiang, analyst at Benchmark, maintained a Buy rating on Alibaba and lowered the price target to $118. Alibaba reported solid profit beat in Q3 but with uncertainty in China, the company is now focused on growth and investing in core businesses. Suspquehanna's Shyam Patil and Mizuho's James Lee also maintained Buy ratings with lowered price targets, while Goldman Sachs' Ronald Keung and Baird's Colin Sebastian maintained Buy ratings with lowered price targets.

BABA